GeneDx Holdings
WGS
$24.02
Share price
13.52%
Change (1 day)
280.67%
Change (1 year)
Categories
GeneDx Holdings (WGS) - Cash on Hand
Cash on Hand as of March 2024 : $0.11 B
According to GeneDx Holdings's latest financial reports the company has $0.11 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
GeneDx Holdings - Cash on Hand chart (from 2020 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.13 B | 5.01% |
| 2022-12-31 | $0.12 B | -69.06% |
| 2021-12-31 | $0.40 B | 270.44% |
| 2020-12-31 | $0.10 B |